Evidence map›Paper›PMID 22040268›Full record

ArticleBMC infectious diseases2011

Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study.

Jon P Furuno, Jennifer K Johnson, Marin L Schweizer, Anayochukwu Uche, Oscar C Stine, Simone M Shurland, Graeme N Forrest

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Neurologic complications of infective endocarditis.Current treatment options in neurology · 2013
    Article
  17. Management of MRSA/GISA, VISA Endocarditis.Current infectious disease reports · 2013
    Article
  18. Community-acquired methicillin-resistant Staphylococcus aureus: the new face of an old foe?Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jon P FurunoOregon Health Science University, Portland, OR, USA.
Jennifer K Johnson
Marin L Schweizer
Anayochukwu Uche
Oscar C Stine
Simone M Shurland
Graeme N Forrest
University of Maryland, Baltimore · USPortland VA Medical Center · USUniversity of Iowa · USValley Hospital · US

Funding

Zonulin Antibodies in Intestinal Permeabilitiy in IDDMM01RR016500 · NCRR · UNIVERSITY OF MARYLAND BALTIMORE · PI OSWALD, LYNN M · 2002 to 2009
$20.2M
Clinical Research Career Development (RMI)K12RR023250 · NCRR · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2005 to 2009
$13.3M
Epidemiology of resistant bacteria in acute-care and long-term care facilitiesK01AI071015 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI FURUNO, JON P · 2008 to 2012
$757k
NCRR NIH HHS 1K12RR023250-04NCRR NIH HHS M01 RR16500NIAID NIH HHS 1K01AI071015-03NIAID NIH HHS K01 AI071015
6 · The paper itself

Abstract

backgroundHIV patients are at increased risk of development of infections and infection-associated poor health outcomes. We aimed to 1) assess the prevalence of USA300 community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) among HIV-infected patients with S. aureus bloodstream infections and. 2) determine risk factors for infective endocarditis and in-hospital mortality among patients in this population.

methodsAll adult HIV-infected patients with documented S. aureus bacteremia admitted to the University of Maryland Medical Center between January 1, 2003 and December 31, 2005 were included. CA-MRSA was defined as a USA 300 MRSA isolate with the MBQBLO spa-type motif and positive for both the arginine catabolic mobile element and Panton-Valentin Leukocidin. Risk factors for S. aureus-associated infective endocarditis and mortality were determined using logistic regression to calculate odds ratios (OR) and 95% confidence intervals (CI). Potential risk factors included demographic variables, comorbid illnesses, and intravenous drug use.

resultsAmong 131 episodes of S. aureus bacteremia, 85 (66%) were MRSA of which 47 (54%) were CA-MRSA. Sixty-three patients (48%) developed endocarditis and 10 patients (8%) died in the hospital on the index admission Patients with CA-MRSA were significantly more likely to develop endocarditis (OR = 2.73, 95% CI = 1.30, 5.71). No other variables including comorbid conditions, current receipt of antiretroviral therapy, pre-culture severity of illness, or CD4 count were significantly associated with endocarditis and none were associated with in-hospital mortality.

conclusionsCA-MRSA was significantly associated with an increased incidence of endocarditis in this cohort of HIV patients with MRSA bacteremia. In populations such as these, in which the prevalence of intravenous drug use and probability of endocarditis are both high, efforts must be made for early detection, which may improve treatment outcomes.

Indexed as

AdultBacteremiaBacterial ToxinsCohort StudiesCommunity-Acquired InfectionsEndocarditis, BacterialExotoxinsFemaleHIV InfectionsHumansInterspersed Repetitive SequencesLeukocidinsMaleMarylandMethicillin-Resistant Staphylococcus aureusMiddle AgedBacterial ToxinsExotoxinsLeukocidinsPanton-Valentine leukocidinStaphylococcal Protein AVirulence Factors

Identifiers

PMID22040268
PMCPMC3214174
OpenAlexW1997044959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.